Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Unknown 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 3Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3Advanced Solid Tumors 1

Interventions

Cisplatin 514Radiotherapy 376Cyclophosphamide 364Carboplatin 356Capecitabine 342Oxaliplatin 334Paclitaxel 331Gemcitabine 320Docetaxel 315Fluorouracil 290Drug Therapy 273Bevacizumab 247apatinib 246camrelizumab 218Etoposide 200Irinotecan 183Doxorubicin 181Leucovorin 163Dexamethasone 160pembrolizumab 154sintilimab 143Neoadjuvant Therapy 143anlotinib 140Blood Specimen Collection 139Pemetrexed 138Cytarabine 138toripalimab 131Surgical Procedures, Operative 131Radiosurgery 127S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × SKLB1028 × Clear all
NCT04716114 2021-11-02

ALIVE

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Unknown
315 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05072522 2021-10-11

A Study of SKLB1028 in Patients With Advanced Solid Tumor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
98 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT04015024 2019-07-16

A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 2 Unknown
30 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02859948 2016-08-09

A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
18 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡